XML 58 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
Debt (Tables)
6 Months Ended
Jun. 30, 2014
Debt Disclosure [Abstract]  
Summary of the Operating Partnership's Outstanding Consolidated Debt
The following is a summary of the Operating Partnership’s outstanding consolidated debt as of June 30, 2014 and December 31, 2013 (dollars in thousands):

 
Stated Interest Rate
 
Effective Interest Rate
 
Principal Balance
 
 
 
 
June 30,
2014
 
December 31,
2013
 
Maturity Date
Mortgage Notes Payable
 
 
 
 
 
 
 
 
 
9900 Belward Campus Drive
5.64
%
 
3.99
%
 
$
10,559

 
$
10,631

 
July 1, 2017
9901 Belward Campus Drive
5.64
%
 
3.99
%
 
13,002

 
13,091

 
July 1, 2017
Center for Life Science | Boston (1)
7.75
%
 
7.75
%
 
—

 
334,447

 
June 30, 2014
100 College Street (2)
2.40
%
 
2.40
%
 
35,885

 
—

 
August 2, 2016
4320 Forest Park Avenue
4.00
%
 
2.70
%
 
21,000

 
21,000

 
June 30, 2015
300 George Street (2)
6.20
%
 
4.91
%
 
45,905

 
—

 
July 1, 2025
Hershey Center for Applied Research
6.15
%
 
4.71
%
 
13,203

 
13,449

 
May 5, 2027
500 Kendall Street (Kendall D)
6.38
%
 
5.45
%
 
56,755

 
57,927

 
December 1, 2018
Shady Grove Road
5.97
%
 
5.97
%
 
142,101

 
143,067

 
September 1, 2016
University of Maryland BioPark I
5.93
%
 
4.69
%
 
16,416

 
16,752

 
May 15, 2025
University of Maryland BioPark II
5.20
%
 
4.33
%
 
62,432

 
62,946

 
September 5, 2021
University of Maryland BioPark Garage
5.20
%
 
4.33
%
 
4,699

 
4,738

 
September 1, 2021
University of Miami Life Science & Technology Park
4.00
%
 
2.89
%
 
20,000

 
20,000

 
February 1, 2016
 
 
 
 
 
441,957

 
698,048

 
 
Unamortized premiums
 
 
 
 
14,077

 
11,276

 
 
Mortgage notes payable, net
 
 
 
 
456,034

 
709,324

 
 
Exchangeable Senior Notes
3.75
%
 
3.75
%
 
180,000

 
180,000

 
January 15, 2030
Notes due 2016
3.85
%
 
3.99
%
 
400,000

 
400,000

 
April 15, 2016
Notes due 2019
2.63
%
 
2.72
%
 
400,000

 
—

 
May 1, 2019
Notes due 2020
6.13
%
 
6.27
%
 
250,000

 
250,000

 
April 15, 2020
Notes due 2022
4.25
%
 
4.36
%
 
250,000

 
250,000

 
July 15, 2022
 
 
 
 
 
1,300,000

 
900,000

 
 
Unamortized discounts
 
 
 
 
(6,754
)
 
(4,917
)
 
 
Unsecured senior notes, net
 
 
 
 
1,293,246

 
895,083

 
 
Term Loan due 2017 - U.S. dollar (3)
1.55
%
 
2.38
%
 
243,596

 
243,596

 
March 30, 2017
Term Loan due 2017 - GBP (3)
1.89
%
 
2.14
%
 
170,510

 
165,190

 
March 30, 2017
Term Loan due 2018
1.35
%
 
1.67
%
 
350,000

 
350,000

 
March 24, 2018
Unsecured senior term loans
 
 
 
 
764,106

 
758,786

 
 
Unsecured line of credit (4)
1.25
%
 
1.25
%
 
155,000

 
128,000

 
March 24, 2018
Total consolidated debt
 
 
 
 
$
2,848,386

 
$
2,671,193

 
 

(1)
On April 1, 2014, the Operating Partnership repaid in full the mortgage loan secured by the Company’s Center for Life Science | Boston property prior to its scheduled maturity date.
(2)
Mortgage notes payable assumed on April 4, 2014 in connection with the acquisition of the related properties.
(3)
In August 2012, the Operating Partnership converted approximately $156.4 million of outstanding borrowings into British pounds sterling (“GBP”) equal to £100.0 million, which was designated as a net investment hedge to mitigate the risk of fluctuations in foreign currency exchange rates. The principal balance represents the U.S. dollar amount based on the exchange rates of $1.71 to £1.00 and $1.65 to £1.00 at June 30, 2014 and December 31, 2013, respectively. The effective interest rate includes the impact of interest rate swap agreements (see Note 9 for further discussion of interest rate swap agreements).
(4)
At June 30, 2014, the Operating Partnership had additional borrowing capacity under the unsecured line of credit of up to approximately $745.0 million.

Principal Payments Due for Operating Partnership's Consolidated Indebtedness
As of June 30, 2014, principal payments due for the Operating Partnership’s consolidated indebtedness (excluding debt premiums and discounts) were as follows (in thousands):

2014
$
4,245

2015
31,784

2016
604,293

2017
446,412

2018
552,804

Thereafter (1)
1,201,525

 
$
2,841,063


(1)
Includes $180.0 million in principal payments of the Exchangeable Senior Notes based on a contractual maturity date of January 15, 2030.